Hemoglobin Level in Elite Speed Skaters from 2000 up to 2005, and its Relationship with Competitive Results

Abstract

We studied the mean hemoglobin (Hb) concentration in elite male and female long track junior and senior speed skaters from 2000 to 2005. In addition, the number of abnormal hematological findings observed over this period of time was investigated. We also studied whether there were differences in Hb concentration between top ranked and lower ranked skaters, and whether a relationship between Hb concentration and competitive results could be observed. The present study shows that the mean Hb level in male and female junior and senior long track speed skaters remained fairly stable and did not change from 2000 through 2005. The number and percentage of abnormal hematological findings were found to vary between 0 and 2 %, and failed to show a clear pattern or trend over the years. There was no difference in mean Hb levels between top ranked and lower ranked skaters, and no meaningful relationship between Hb concentration and ranking could be found.

Key words

Blood testing - hemoglobin level - sport performance

References

• 1 Birkeland K I, Stray-Gundersen J, Hemmersbach P, Hallen J, Haug E, Bahr R. Effect of rhEPO administration on serum levels of sTfR and cycling performance.  Med Sci Sports Exerc. 2000;  32 1238-1243
• 2 FIS rules 2005 .http://www.fis-ski.com/rulesandpublications/medicaldoping.html
• 3 Foster C, De Koning J. Physiological perspectives of speed skating. Gemser H, deKoning J, van Ingen Schenau GJ Handbook of Competitive Speed Skating. Lausanne, Switzerland; International Skating Union 1999: 117-137
• 4 Gore C J, Hahn G, Burge C M, Telford R D. V·O_2max and hemoglobin mass of trained athletes during high intensity training.  Int J Sports Med. 1997;  18 477-482
• 5 Gore C J, Parisotto R, Ashenden M J, Stray-Gundersen J, Sharpe K, Hopkins W, Emslie K R, Howe C, Trout G J, Kazlauskas R, Hahm A G. Second-generation blood tests to detect erythropoietin abuse in athletes.  Haematologica. 2003;  88 333-344
• 6 Guglielmini C, Casoni M, Patracchini M, Manfredini F, Grazzi G, Ferrari M, Concini F. Reduction of Hb levels during the racing season in nonsideropenic professional cyclists.  Int J Sports Med. 1989;  10 352-356
• 7 Hahn A G, Gore C J. The effect of altitude on cycling performance: a challenge to traditional concepts.  Sports Med. 2001;  31 533-557
• 8 IBU .http://www.biathlonworld.com/media/media_0007920.PDF 2005
• 9 ISU .Communication 1282, (www.isu.org). 2004
• 10 Kling G. Using the ADVIA 120 for sports events: calibration procedures. Internal Report. Bayer Corporation 2000
• 11 Kuipers H, Brouwer T, Dubravcic-Simunjak S, Moran J, Mitchell D, Shobe J, Sakai H, Stray-Gundersen J, Vanhoutvin S. Hemoglobin and hematocrit values after saline infusion and tourniquet.  Int J Sports Med. 2005;  26 405-408
• 12 Lippi G, Franchini M, Guidi G C. Hematological testing and anti doping policies.  Int J Sports Med. 2005;  26 508-509
• 13 Robinson N, Schattenberg L, Zorzoli M, Mangin P, Saugy M. Haematological analysis conducted at the departure of the Tour de France 2001.  Int J Sports Med. 2005;  26 200-207
• 14 Rusko H K, Tikkanen H O, Peltnen J E. Altitude and endurance training.  J Sports Sci. 2004;  22 928-944
• 15 Stray-Gundersen J, Videman T, Penttilä I, Inggard L. Abnormal hematologic profiles in elite cross-country skiers: blood doping or?.  Clin J Sports Med. 2003;  13 132-137
• 16 UCI .http://www.uci.ch/english/about/rules_2004/ch13.pdf 2003
• 17 Videman T, Leriem I, Hemmingsson P, Turner M S, Rousseau-Bianchi M P, Jenourne P, Raas E, Schönhuber H, Rusko H, Stray-Gundersen J. Changes in hemoglobin values in elite cross-country skiers from 1987 to 1999.  Scand J Med Sci Sports. 2000;  10 98-102
• 18 Wilber R L. Detection of DNA-recombinant human epoetin-alfa as a pharmacological ergogenic aid.  Sports Med. 2002;  32 125-142